| No Longer Available | N/A | | NA | Navitoclax, ABT-263, Venetoclax, Venclexta, ABT-199, GDC-0199 | AbbVie | Myelofibrosis, Acute Lymphocytic Leukemia (ALL), Lymphoblastic Lymphoma | | | | |
NCT05215405: Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL |
|
|
| No Longer Available | N/A | | US | Venetoclax, ABT-199, Navitoclax, ABT-263 | Kathleen Ludwig | Relapsed Childhood ALL, Relapsed Childhood Lymphoblastic Lymphoma | | | | |
